NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) currently has 28 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Anson Funds Management LP | 31 Dec, 2025 | 3,043,957 | 1,018,853 | 50.31% | $8,249,123.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 729,842 | 194,886 | 36.43% | $1,977,871.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Dec, 2025 | 366,631 | 366,631 | 0.00% | $993,570.00 |
| AdvisorShares Investments LLC | 31 Dec, 2025 | 328,004 | -14,132 | -4.13% | $888,891.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 218,866 | 33,004 | 17.76% | $593,212.00 |
| Bleakley Financial Group, LLC | 31 Dec, 2025 | 117,204 | 117,204 | 0.00% | $317,623.00 |
| STATE STREET CORP | 31 Dec, 2025 | 86,984 | 10,700 | 14.03% | $235,727.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 82,654 | 17,242 | 26.36% | $223,992.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 68,665 | -16,834 | -19.69% | $186,082.00 |
| Global Retirement Partners, LLC | 31 Dec, 2025 | 39,300 | 39,300 | 0.00% | $106,503.00 |
| One Wealth Management Investment & Advisory Services, LLC | 31 Dec, 2025 | 37,873 | 9,882 | 35.30% | $102,636.00 |
| Chicago Partners Investment Group LLC | 31 Dec, 2025 | 33,421 | -8,573 | -20.41% | $72,524.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 28,947 | 346 | 1.21% | $78,446.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 17,436 | -34,896 | -66.68% | $47,252.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 15,979 | 15,979 | 0.00% | $43,303.00 |
| SJBENEN ADVISORY, LLC | 31 Dec, 2025 | 15,000 | 15,000 | 0.00% | $40,650.00 |
| Ethos Financial Group, LLC | 31 Dec, 2025 | 11,900 | 0 | 0.00% | $32,249.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 10,029 | -1,051 | -9.49% | $27,179.00 |
| UBS Group AG | 31 Dec, 2025 | 3,538 | -149,310 | -97.69% | $9,588.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 3,239 | -161 | -4.74% | $8,777.00 |